相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Brian D. Hudson et al.
MOLECULAR PHARMACOLOGY (2010)
Cannabinoid Agonists Stimulate [3H] GABA Release in the Globus Pallidus of the Rat When Gi Protein-Receptor Coupling Is Restricted: Role of Dopamine D2 Receptors
Brenda Gonzalez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
'7TM Receptor Allostery: Putting Numbers to Shapeshifting Proteins
Terry P. Kenakin
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
George Kunos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Prostamides (prostaglandin-ethanolamides) and their pharmacology
D. F. Woodward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Phytochemical and genetic analyses of ancient cannabis from Central Asia
Ethan B. Russo et al.
JOURNAL OF EXPERIMENTAL BOTANY (2008)
Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors
Dai-Fei Wu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Cannabinoid receptors: Where they are and what they do
K. Mackie
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Mauro Maccarrone et al.
NATURE NEUROSCIENCE (2008)
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown
Ekaterina A. Placzek et al.
NEUROPHARMACOLOGY (2008)
Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling
Tanya L. Daigle et al.
NEUROPHARMACOLOGY (2008)
Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain
L. Cristino et al.
NEUROSCIENCE (2008)
Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization
Lenka Mikasova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Novel cannabinoid receptors
A. J. Brown
BRITISH JOURNAL OF PHARMACOLOGY (2007)
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
J. G. Horswill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The complications of promiscuity: endocannabinoid action and metabolism
S. P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant
Jay J. Paquette et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Functional selectivity through protean and biased agonism: Who steers the ship?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2007)
Allosterism and cannabinoid CB1 receptors:: the shape of things to come
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Striatal adenosine A2A and Cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of Cannabinoids
Paulina Carriba et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Biochemistry and pharmacology of endovanilloids
Katarzyna Starowicz et al.
PHARMACOLOGY & THERAPEUTICS (2007)
The toxicology of cannabis and cannabis prohibition
Franjo Grotenhermen
CHEMISTRY & BIODIVERSITY (2007)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
James Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases
Luigi Bellocchio et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18
Masashi Kohno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
Krisztina Monory et al.
NEURON (2006)
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
Murat Oz
PHARMACOLOGY & THERAPEUTICS (2006)
History of cannabis as a medicine:: a review
Antonio Waldo Zuardi
REVISTA BRASILEIRA DE PSIQUIATRIA (2006)
Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission
Maria R. Domenici et al.
JOURNAL OF NEUROSCIENCE (2006)
WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction
JY Shim et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors
C Leterrier et al.
JOURNAL OF NEUROSCIENCE (2006)
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum
Y Kawamura et al.
JOURNAL OF NEUROSCIENCE (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
HA Overton et al.
CELL METABOLISM (2006)
A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists
V Di Marzo
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis
Sabine Steffens et al.
FUTURE CARDIOLOGY (2006)
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells
D Sarnataro et al.
FEBS LETTERS (2005)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
The search for the palmitoylethanolamide receptor
J LoVerme et al.
LIFE SCIENCES (2005)
Cannabinoid receptor homo- and heterodimerization
K Mackie
LIFE SCIENCES (2005)
Endocannabinoid signaling in rat somatosensory cortex:: Laminar differences and involvement of specific interneuron types
AL Bodor et al.
JOURNAL OF NEUROSCIENCE (2005)
The endocannabinoid signalling system: Biochemical aspects
T Bisogno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats
J Fu et al.
NEUROPHARMACOLOGY (2005)
Evidence for novel cannabinoid receptors
M Begg et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Emerging properties of cannabinoid medicines in management of multiple sclerosis
G Pryce et al.
TRENDS IN NEUROSCIENCES (2005)
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
CS Kearn et al.
MOLECULAR PHARMACOLOGY (2005)
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells -: Implications for anandamide-induced apoptosis
M Bari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The expanding field of cannabimimetic and related lipid mediators
HB Bradshaw et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
RG Pertwee
AAPS JOURNAL (2005)
The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders
U Schneider et al.
NERVENARZT (2005)
G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?
B Chini et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor
A Jarrahian et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The biology of peroxisome proliferator -: Activated receptors -: Relationship with lipid metabolism and insulin sensitivity
P Ferré
DIABETES (2004)
Cannabinoid physiology and pharmacology: 30 years of progress
AC Howlett et al.
NEUROPHARMACOLOGY (2004)
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
JD Leggett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity
S Mato et al.
NATURE NEUROSCIENCE (2004)
Signaling pathways involved in the development of cannabinoid tolerance
BR Martin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide
MJ McFarland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias
B Ferrer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Hypersensitization of the orexin 1 receptor by the CB1 receptor -: Evidence for cross-talk blocked by the specific CB1 antagonist, SR141716
S Hilairet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CBI receptor agonist WIN 55212-2
SF Fan et al.
VISUAL NEUROSCIENCE (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors
PH Reggio
CURRENT PHARMACEUTICAL DESIGN (2003)
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example
J Wager-Miller et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Regulation of anandamide tissue levels by N-arachidonylglycine
SH Burstein et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol:: Conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase
M van der Stelt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia
J Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
AC Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
The cannabinoid agonist DALN dependent calcium-channels positively modulates L-type voltage-in N18TG2 neuroblastoma cells
V Rubovitch et al.
MOLECULAR BRAIN RESEARCH (2002)
Oxidative metabolism of endocannabinoids
KR Kozak et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain
SM Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An anorexic lipid mediator regulated by feeding
FR de Fonseca et al.
NATURE (2001)
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes
JR Savinainen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus
SJ Craib et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Receptor-dependent formation of endogenous cannabinoids in cortical neurons
N Stella et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The CYPP450 arachidonic acid monooxygenases: From cell signaling to blood pressure regulation
JH Capdevila et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
T Bisogno et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice:: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain
V Di Marzo et al.
JOURNAL OF NEUROCHEMISTRY (2000)
A historical overview of chemical research on cannabinoids
R Mechoulam et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice
CE Bass et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol
M Beltramo et al.
NEUROREPORT (2000)
Oxidative metabolism of anandamide
SH Burstein et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
N Hajos et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
